Propacetamol

PreclinicalSmall molecule

YYonsei University

Propacetamol is one of 145 small molecule programs targeting Hernia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

144

Competitors

Pipeline

Status by Indication[3][1]

Indication

Atrial FibrillationActive, not recruiting

Cesarean SectionActive, not recruiting

Post Operative PainCompleted

High RiskCompleted

Atrial FibrillationPreclinical

Active, not recruiting

Cesarean SectionPreclinical

Active, not recruiting

Post Operative PainPreclinical

Completed

High RiskPreclinical

Completed

Competition

Competitive Landscape

137 competitors in Atrial Fibrillation

#DrugCompanyPhaseTrials

Calquence

AstraZeneca

Preclinical

1 2

Rituxan

Coumadin

3 4

Brukinsa

BBeOne Medicines

Preclinical

1 5

Imbruvica

PPharmacyclics LLC.

Preclinical

1 6

Versed

CConrado Roberto Hoffmann Filho

Preclinical

1 7

Ondexxya

UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology

Preclinical

1 8

Romazicon

CConrado Roberto Hoffmann Filho

Preclinical

1 9

Statin

Bristol-Myers Squibb

Preclinical

1 10

Low-Molecular-Weight Heparin

Daiichi Sankyo

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Cesarean Section1 trial

Propacetamol to Reduce Post Cesarean Section Uterine Contraction Pain

Completed·MMackay Memorial Hospital·N/A·NCT03878082·100 enrolled

Hernia1 trial

Comparison of the Effect of Propacetamol, Ibuprofen or Their Combination on Postoperative Pain and Quality of Recovery After Laparoscopic Hernia Repair in Children

Completed·YYonsei University·N/A·NCT03352362·159 enrolled

High Risk1 trial

The Opioid-sparing Effect and Reduced PONV Using Propacetamol in PCA Among Patients With High Risk of PONV

Completed·YYonsei University·N/A·NCT02116257·108 enrolled

Post Operative Pain1 trial

Combination Effect of Nefopam With Propacetamol for Postoperative Pain After Thyroidectomy

Completed·YYonsei University·N/A·NCT02577068·84 enrolled

Atrial Fibrillation1 trial

The Effect of Additional Propacetamol Infusion on Post Procedural Outcome and Opioid Consumption During Catheter Ablation of Atrial Fibrillation.

Completed·YYonsei University·N/A·NCT02515188·98 enrolled

1 more indication

Postoperative Quality of Recovery1 trial

A Comparison of Nefopam-propacetamol Combination and Propacetamol for Postoperative Quality of Recovery After Laparoscopic Nephrectomy

Completed·YYonsei University·N/A·NCT01833728·16 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Propacetamol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Propacetamol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Propacetamol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Yonsei University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: YYonsei University

Propacetamol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Cesarean Section1 trial

Hernia1 trial

High Risk1 trial

Post Operative Pain1 trial

Atrial Fibrillation1 trial

Postoperative Quality of Recovery1 trial

References

Drug Info

Quick Facts

Related News